Skip to content

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01820650
Enrollment
359
Registered
2013-03-29
Start date
2013-02-28
Completion date
2023-10-31
Last updated
2023-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Knee

Keywords

osteoarthritis, knee replacement, patient-specific

Brief summary

This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis.

Detailed description

If the patient has previously received a standard total knee replacement in their contralateral knee, the primary endpoint questionnaire and some secondary endpoint questionnaires will be completed regarding BOTH their iTotal® CR knee and their standard total knee for all time points where questionnaires are required by the protocol.

Interventions

DEVICEiTotal G2 CR Knee Replacement System

Total Knee replacement

Sponsors

Restor3D
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical condition included in the approved Indications For Use for the iTotal® CR * Osteoarthritis, as confirmed by the investigator's assessment of disease status at screening visit that warrants a TKR procedure. Disease status is assessed by Clinical and Radiographic assessment. * Willingness to participate in the clinical study, to give informed consent and to attend all follow-up visits * \> 18 years of age

Exclusion criteria

* Simultaneous bilateral procedure required * BMI \> 40 * Active malignancy (defined as a history of any invasive malignancy - except non-melanoma skin cancer), unless patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years * Poorly Controlled diabetes * Neuromuscular conditions which prevent patient from participating in study activities * Active local or systemic infection * Immunocompromised * Fibromyalgia or other general body pain related condition * Rheumatoid arthritis or other forms of inflammatory joint disease * Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in the area of the joint to be operated to an extent that the procedure is unjustified * Diagnosed with or receiving treatment for Osteoporosis * Other physical disability affecting the hips, spine, or contralateral knee. * Severe instability due to advanced loss of osteochondral structure * Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO) * Compromised PCL or collateral ligament * Severe fixed valgus or varus deformity of \>15º * Extensor lag \> 15 º * Fixed flexion contracture ≥ 15 º * Unwilling or unable to comply with study requirements * Participation in another clinical study which would confound results * Allergy to any of the implant materials

Design outcomes

Primary

MeasureTime frame
2011 Knee Society Score1 Year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026